GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bonus BioGroup Ltd (OTCPK:BBIXF) » Definitions » Total Equity

BBIXF (Bonus BioGroup) Total Equity : $2.39 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bonus BioGroup Total Equity?

Bonus BioGroup's total equity for the quarter that ended in Sep. 2024 was $2.39 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Bonus BioGroup Total Equity Historical Data

The historical data trend for Bonus BioGroup's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonus BioGroup Total Equity Chart

Bonus BioGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.74 8.36 23.01 15.37 7.99

Bonus BioGroup Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 7.99 5.99 4.20 2.39

Bonus BioGroup Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bonus BioGroup's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=12.232-4.246
=7.99

Bonus BioGroup's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=7.197-4.805
=2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bonus BioGroup Total Equity Related Terms

Thank you for viewing the detailed overview of Bonus BioGroup's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonus BioGroup Business Description

Traded in Other Exchanges
Address
Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.

Bonus BioGroup Headlines